Transgender hormone therapy (female-to-male) to individuals taking bioidentical hormones in the form of testosterone (including esters) and do not apply to those taking synthetic AAS (e.g., nandrolone) or dihydrotestosterone. Transgender hormone therapy (female-to-male) Transgender hormone therapy of the female-to-male (FTM) type, also known as masculinizing hormone therapy, is a form of hormone therapy and sex reassignment therapy which is used to change the secondary sexual characteristics of transgender people from feminine (or androgynous) to masculine. It is one of two types of transgender hormone therapy (the other being male-to-female), and is predominantly used to treat transgender men and other transmasculine individuals. Some intersex people
Trophic hormone causes hyperplasia of enterochromaffin cells which may transform into carcinoid tumors. Trophic hormone Trophic hormone is a hormone that has a growth effect, hyperplasia or hypertrophy, on the tissue it is stimulating. The term "trophic" is from Ancient Greek τροφικός ("trophikós") meaning "pertaining to food or nourishment", here used to mean "growth"; this is the same origin as "atrophy." This should not be confused with "tropic," as in the similar-sounding tropic hormone – the words and concepts are both unrelated. A key example of this is thyroid-stimulating hormone stimulating the thyroid; excess thyroid-stimulating hormone can create a goitre. Trophic hormones